Long Non-coding RNAs in Hematological Malignancies: Translating Basic Techniques into Diagnostic and Therapeutic Strategies

Overview

Journal J Hematol Oncol

Publisher Biomed Central

Specialties Hematology
Oncology

Date 2018 Nov 24

PMID 30466456

Citations 17

Authors

Nonthaphat Kent Wong

Chien-Ling Huang

Rashidul Islam

Shea Ping Yip

Affiliations

Soon will be listed here.

Abstract

Recent studies have revealed that non-coding regions comprise the vast majority of the human genome and long non-coding RNAs (lncRNAs) are a diverse class of non-coding RNAs that has been implicated in a variety of biological processes. Abnormal expression of lncRNAs has also been linked to different human diseases including cancers, yet the regulatory mechanisms and functional effects of lncRNAs are still ambiguous, and the molecular details also need to be confirmed. Unlike protein-coding gene, it is much more challenging to unravel the roles of lncRNAs owing to their unique and complex features such as functional diversity and low conservation among species, which greatly hamper their experimental characterization. In this review, we summarize and discuss both conventional and advanced approaches for the identification and functional characterization of lncRNAs related to hematological malignancies. In particular, the utility and advancement of clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system as gene-editing tools are envisioned to facilitate the molecular dissection of lncRNAs via different knock-in/out strategies. Besides experimental considerations specific to lncRNAs, the roles of lncRNAs in the pathogenesis and progression of leukemia are also highlighted in the review. We expect that these insights may ultimately lead to clinical applications including development of biomarkers and novel therapeutic approaches targeting lncRNAs.

Citing Articles

The interplay of p16INK4a and non-coding RNAs: bridging cellular senescence, aging, and cancer.

Balaraman A, Afzal M, Moglad E, Babu M, Priya G, Bansal P Biogerontology. 2025; 26(2):50.

PMID: 39907830 DOI: 10.1007/s10522-025-10194-2.

Combined replacement of lnc-MEG3 and miR-155 elicit tumor suppression in multiple myeloma.

El-Khazragy N, Abdelrahman S, Darwish A, Hemida E Epigenomics. 2025; 17(3):167-177.

PMID: 39815805 PMC: 11816889. DOI: 10.1080/17501911.2025.2453413.

The Role of Non-Coding RNAs in Myelodysplastic Neoplasms.

Georgoulis V, Koumpis E, Hatzimichael E Cancers (Basel). 2023; 15(19).

PMID: 37835504 PMC: 10571949. DOI: 10.3390/cancers15194810.

Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine.

Lucansky V, Holubekova V, Kolkova Z, Halasova E, Samec M, Golubnitschaja O EPMA J. 2023; 14(2):201-217.

PMID: 37275547 PMC: 10201107. DOI: 10.1007/s13167-023-00324-6.

Quantitative Expression of , lncRNA CCDC18-AS1, and lncRNA LINC01343 in Human Breast Cancer as the Regulator Biomarkers in a Novel ceRNA Network: Based on Bioinformatics and Experimental Analyses.

Rishehri M, Etemadi T, Pisheh L, Koufigar G, Azadeh M Genet Res (Camb). 2022; 2022:6787791.

PMID: 36160032 PMC: 9484965. DOI: 10.1155/2022/6787791.

References

Lefever S, Anckaert J, Volders P, Luypaert M, Vandesompele J, Mestdagh P . decodeRNA- predicting non-coding RNA functions using guilt-by-association. Database (Oxford). 2017; 2017. PMC: 5502368. DOI: 10.1093/database/bax042. View

Li Z, Yang L, Liu X, Nie Z, Luo J . Long noncoding RNA MEG3 inhibits proliferation of chronic myeloid leukemia cells by sponging microRNA21. Biomed Pharmacother. 2018; 104:181-192. DOI: 10.1016/j.biopha.2018.05.047. View

Chang K, Marran K, Valentine A, Hannon G . RNAi in cultured mammalian cells using synthetic siRNAs. Cold Spring Harb Protoc. 2012; 2012(9):957-61. PMC: 3541682. DOI: 10.1101/pdb.prot071076. View

Gutschner T, Baas M, Diederichs S . Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res. 2011; 21(11):1944-54. PMC: 3205578. DOI: 10.1101/gr.122358.111. View

Lee G, Dobi A, Srivastava S . Prostate cancer: diagnostic performance of the PCA3 urine test. Nat Rev Urol. 2011; 8(3):123-4. DOI: 10.1038/nrurol.2011.10. View

Yap K, Li S, Munoz-Cabello A, Raguz S, Zeng L, Mujtaba S . Molecular interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell. 2010; 38(5):662-74. PMC: 2886305. DOI: 10.1016/j.molcel.2010.03.021. View

Wilkes M, Repellin C, Sakamoto K . Beyond mRNA: The role of non-coding RNAs in normal and aberrant hematopoiesis. Mol Genet Metab. 2017; 122(3):28-38. PMC: 5722683. DOI: 10.1016/j.ymgme.2017.07.008. View

Turturici G, Tinnirello R, Sconzo G, Geraci F . Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol. 2014; 306(7):C621-33. DOI: 10.1152/ajpcell.00228.2013. View

Yu W, Gius D, Onyango P, Muldoon-Jacobs K, Karp J, Feinberg A . Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature. 2008; 451(7175):202-6. PMC: 2743558. DOI: 10.1038/nature06468. View

10.

Cai H, Liu X, Zheng J, Xue Y, Ma J, Xi Z . Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. Oncogene. 2016; 36(3):318-331. DOI: 10.1038/onc.2016.212. View

11.

Perez-Pinera P, Kocak D, Vockley C, Adler A, Kabadi A, Polstein L . RNA-guided gene activation by CRISPR-Cas9-based transcription factors. Nat Methods. 2013; 10(10):973-6. PMC: 3911785. DOI: 10.1038/nmeth.2600. View

12.

Bussemakers M, van Bokhoven A, Verhaegh G, Smit F, Karthaus H, Schalken J . DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res. 1999; 59(23):5975-9. View

13.

Redrup L, Branco M, Perdeaux E, Krueger C, Lewis A, Santos F . The long noncoding RNA Kcnq1ot1 organises a lineage-specific nuclear domain for epigenetic gene silencing. Development. 2009; 136(4):525-30. PMC: 2685953. DOI: 10.1242/dev.031328. View

14.

Li Z, Huang C, Bao C, Chen L, Lin M, Wang X . Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015; 22(3):256-64. DOI: 10.1038/nsmb.2959. View

15.

Niranjanakumari S, Lasda E, Brazas R, Garcia-Blanco M . Reversible cross-linking combined with immunoprecipitation to study RNA-protein interactions in vivo. Methods. 2002; 26(2):182-90. DOI: 10.1016/S1046-2023(02)00021-X. View

16.

Engreitz J, Pandya-Jones A, McDonel P, Shishkin A, Sirokman K, Surka C . The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science. 2013; 341(6147):1237973. PMC: 3778663. DOI: 10.1126/science.1237973. View

17.

Thery C . Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011; 3:15. PMC: 3155154. DOI: 10.3410/B3-15. View

18.

Ulitsky I, Bartel D . lincRNAs: genomics, evolution, and mechanisms. Cell. 2013; 154(1):26-46. PMC: 3924787. DOI: 10.1016/j.cell.2013.06.020. View

19.

Mattick J . The genetic signatures of noncoding RNAs. PLoS Genet. 2009; 5(4):e1000459. PMC: 2667263. DOI: 10.1371/journal.pgen.1000459. View

20.

Kotake Y, Goto T, Naemura M, Inoue Y, Okamoto H, Tahara K . Long Noncoding RNA PANDA Positively Regulates Proliferation of Osteosarcoma Cells. Anticancer Res. 2016; 37(1):81-85. DOI: 10.21873/anticanres.11292. View